Teleassistance for patients with type 1 diabetes during the COVID-19 pandemic: Results of a pilot study
| العنوان: | Teleassistance for patients with type 1 diabetes during the COVID-19 pandemic: Results of a pilot study |
|---|---|
| المؤلفون: | Katherine Esposito, Concetta Irace, Maria Ida Maiorino, Agostino Gnasso, Martina Parise, Dario Pitocco, Linda Tartaglione, Antonio Cutruzzolà |
| المساهمون: | Parise, M., Tartaglione, L., Cutruzzola, A., Maiorino, M. I., Esposito, K., Pitocco, D., Gnasso, A., Irace, C. |
| المصدر: | Journal of Medical Internet Research, Vol 23, Iss 4, p e24552 (2021) Journal of Medical Internet Research |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Male, Technology, medicine.medical_treatment, Pilot Projects, Effectiveness, Telehealth, Diabete, 0302 clinical medicine, Insulin, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Teleassistance, lcsh:Public aspects of medicine, Diabetes, Effectivene, Telemedicine, Management, Type 1 diabetes, lcsh:R858-859.7, Female, Human, Adult, medicine.medical_specialty, Type 1 diabete, 030209 endocrinology & metabolism, Health Informatics, lcsh:Computer applications to medicine. Medical informatics, Chronic disease, 03 medical and health sciences, Diabetes mellitus, Internal medicine, Blood Glucose Self-Monitoring, medicine, Humans, Hypoglycemic Agents, Pilot Project, Glycemic, Original Paper, Hypoglycemic Agent, business.industry, SARS-CoV-2, COVID-19, Settore MED/13 - ENDOCRINOLOGIA, lcsh:RA1-1270, medicine.disease, Prospective Studie, Diabetes Mellitus, Type 1, Time in range, Observational study, business |
| الوصف: | Background Telemedicine use in chronic disease management has markedly increased during health emergencies due to COVID-19. Diabetes and technologies supporting diabetes care, including glucose monitoring devices, software analyzing glucose data, and insulin delivering systems, would facilitate remote and structured disease management. Indeed, most of the currently available technologies to store and transfer web-based data to be shared with health care providers. Objective During the COVID-19 pandemic, we provided our patients the opportunity to manage their diabetes remotely by implementing technology. Therefore, this study aimed to evaluate the effectiveness of 2 virtual visits on glycemic control parameters among patients with type 1 diabetes (T1D) during the lockdown period. Methods This prospective observational study included T1D patients who completed 2 virtual visits during the lockdown period. The glucose outcomes that reflected the benefits of the virtual consultation were time in range (TIR), time above range, time below range, mean daily glucose, glucose management indicator (GMI), and glycemic variability. This metric was generated using specific computer programs that automatically upload data from the devices used to monitor blood or interstitial glucose levels. If needed, we changed the ongoing treatment at the first virtual visit. Results Among 209 eligible patients with T1D, 166 completed 2 virtual visits, 35 failed to download glucose data, and 8 declined the visit. Among the patients not included in the study, we observed a significantly lower proportion of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) users (n=7/43, 16% vs n=155/166, 93.4% and n=9/43, 21% vs n=128/166, 77.1%, respectively; P Conclusions These findings indicate that the structured virtual visits help maintain and improve glycemic control in situations where in-person visits are not feasible. |
| اللغة: | English |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::698d397dba483f57bcdb280c2beb3c4dTest http://hdl.handle.net/11591/467168Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....698d397dba483f57bcdb280c2beb3c4d |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |